Picture of Medivir AB logo

MVIR Medivir AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Brief: Medivir: IGM Biosciences Initiates Birinapant Clinical Study

Nov 4 (Reuters) - Medivir AB  MVIRb.ST :
    * BIRINAPANT CLINICAL STUDY INITIATED BY IGM BIOSCIENCES
    * UPON SIGNING DEAL WITH IGM BIOSCIENCES, CO RECEIVED USD 1
MILLION, WHICH WILL NOW BE FOLLOWED BY AN ADDITIONAL USD 1.5
MILLION

Source text for Eikon:  ID:nWkr2MnLXH 
Further company coverage:  MVIRb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Medivir AB

See all news